Abstract
Fanconi anemia (FA) is an autosomal recessive chromosomal instability disorder caused by mutations in one of seven known genes (FANCA,C,D2,E,F,G and BRCA2). Mutations in the FANCA gene are the most prevalent, accounting for two-thirds of FA cases. Affected individuals have greatly increased risks of acute myeloid leukemia (AML). This raises the question as to whether inherited or acquired mutations in FA genes might be involved in the development of sporadic AML. Quantitative fluorescent PCR was used to screen archival DNA from sporadic AML cases for FANCA deletions, which account for 40% of FANCA mutations in FA homozygotes. Four heterozygous deletions were found in 101 samples screened, which is 35-fold higher than the expected population frequency for germline FANCA deletions (P<0.0001). Sequencing FANCA in the AML samples with FANCA deletions did not detect mutations in the second allele and there was no evidence of epigenetic silencing by hypermethylation. However, real-time quantitative PCR analysis in these samples showed reduced expression of FANCA compared to nondeleted AML samples and to controls. These findings suggest that gene deletions and reduced expression of FANCA may be involved in the promotion of genetic instability in a subset of cases of sporadic AML.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Auerbach A, Buchwald M, Joenje H . Fanconi anaemia. In: Vogelstein B, Kinzler KW (eds). The Genetic Basis of Human Cancer. New York: McGraw-Hill Inc., 1999, pp 317–332.
Alter BP . Fanconi's anemia and malignancies. Am J Hematol 1996; 53: 99–110.
Kutler DI, Singh B, Satagopan J, Batish SD, Berwick M, Giampietro PF et al. A 20 year perspective of the International Fanconi Anemia Registry (IFAR). Blood 2003; 101: 1249–1256.
Rosenberg PS, Greene MH, Alter BP . Cancer incidence in persons with Fanconi's anemia. Blood 2003; 101: 822–825.
Joenje H, Oostra AB, Wijker M, di Summa FM, van Berkel CG, Rooimans MA et al. Evidence for at least eight Fanconi anemia genes. Am J Hum Genet 1997; 61: 940–944.
Lo Ten Foe JR, Rooimans MA, Bosnoyan-Collins L, Alon N, Wijker M, Parker L et al. Expression cloning of a cDNA for the major Fanconi anaemia gene, FAA. Nat Genet 1996; 14: 320–323.
The Fanconi Anaemia/Breast Cancer Consortium. Positional cloning of the Fanconi anaemia group A gene. Nat Genet 1996; 14: 324–328.
Strathdee CA, Duncan AM, Buchwald M . Evidence for at least four Fanconi anaemia genes including FACC on chromosome 9. Nat Genet 1992; 1: 196–198.
Timmers C, Taniguchi T, Hejna J, Reifsteck C, Lucas L, Bruun D et al. Positional cloning of a novel Fanconi anemia gene, FANCD2. Mol Cell 2001; 7: 241–248.
de Winter JP, Rooimans MA, van Der Weel L, van Berkel CG, Alon N, Bosnoyan-Collins L et al. The Fanconi anaemia gene FANCF encodes a novel protein with homology to ROM. Nat Genet 2000; 24: 15–16.
de Winter JP, Leveille F, van Berkel CG, Rooimans MA, van Der Weel L, Steltenpool J et al. Isolation of a cDNA representing the Fanconi anemia complementation group E gene. Am J Hum Genet 2000; 67: 1306–1308.
de Winter JP, Waisfisz Q, Rooimans MA, Van Berkel CGM, Bosnoyan-Collins L, Alon N et al. The Fanconi anaemia group G gene FANCG is identical with XRCC9. Nat Genet 1998; 20: 281–283.
Howlett NG, Taniguchi T, Olson S, Cox B, Waisfisz Q, De Die-Smulders C et al. Biallelic inactivation of BRCA2 in Fanconi anemia. Science 2002; 297: 606–609.
Swift M . Fanconi's anaemia in the genetics of neoplasia. Nature 1971; 230: 370–373.
Swift M, Caldwell RJ, Chase C . Reassessment of cancer predisposition of Fanconi anemia heterozygotes. J Natl Cancer Inst 1980; 65: 863–867.
Lensch MW, Rathbun RK, Olson SB, Jones GR, Bagby Jr GC . Selective pressure as an essential force in molecular evolution of myeloid leukemic clones: a view from the window of Fanconi anemia. Leukemia 1999; 13: 1784–1789.
Stoppa-Lyonnet D, Soulier J, Lauge A, Dastot H, Garand R, Sigaux F et al. Inactivation of the ATM gene in T-cell prolymphocytic leukemias. Blood 1998; 91: 3920–3926.
Vorechovsky I, Luo L, Dyer MJ, Catovsky D, Amlot PL, Yaxley JC et al. Clustering of missense mutations in the ataxia-telangiectasia gene in a sporadic T-cell leukaemia. Nat Genet 1997; 17: 96–99.
Stilgenbauer S, Schaffner C, Litterst A, Liebisch P, Gilad S, Bar-Shira A et al. Biallelic mutations in the ATM gene in T-prolymphocytic leukemia. Nat Med 1997; 3: 1155–1159.
Stankovic T, Weber P, Stewart G, Bedenham T, Murray J, Byrd PJ et al. Inactivation of ataxia telangiectasia mutated gene in B-cell chronic lymphocytic leukaemia. Lancet 1999; 353: 26–29.
Watts JA, Morley M, Burdick JT, Fiori JL, Ewens WJ, Spielman RS et al. Gene expression phenotype in heterozygous carriers of ataxia telangiectasia. Am J Hum Genet 2002; 71: 791–800.
Condie A, Powles RL, Hudson CD, Sheperd V, Bevan S, Yuille MR et al. Analysis of the Fanconi anaemia complementation group A gene in acute myeloid leukaemia. Leukemia Lymphoma 2002; 43: 1849–1853.
Wijker M, Morgan NV, Herterich S, van Berkel CG, Tipping AJ, Gross HJ et al. Heterogeneous spectrum of mutations in the Fanconi anaemia group A gene. Eur J Hum Genet 1999; 7: 52–59.
Barber LM, McGrath HE, Meyer S, Will AM, Birch JM, Eden OB et al. Constitutional sequence variation in the Fanconi anaemia group C (FANCC) gene in childhood acute myeloid leukaemia. Br J Haematol 2003; 121: 57–62.
Xie Y, de Winter JP, Waisfisz Q, Nieuwint AW, Scheper RJ, Arwert F et al. Aberrant Fanconi anaemia protein profiles in acute myeloid leukaemia cells. Br J Haematol 2000; 111: 1057–1064.
Lensch MW, Tischkowitz M, Christianson TA, Reifsteck CA, Speckhart SA, Jakobs PM et al. Acquired FANCA dysfunction and cytogenetic instability in adult acute myelogenous leukemia. Blood 2003; 102: 7–16.
Levran O, Erlich T, Magdalena N, Gregory JJ, Batish SD, Verlander PC et al. Sequence variation in the Fanconi anemia gene FAA. Proc Natl Acad Sci USA 1997; 94: 13051–13056.
Morgan NV, Tipping AJ, Joenje H, Mathew CG . High frequency of large intragenic deletions in the Fanconi anemia group A gene. Am J Hum Genet 1999; 65: 1330–1341.
Savino M, Ianzano L, Strippoli P, Ramenghi U, Arslanian A, Bagnara GP et al. Mutations of the Fanconi anemia group A gene (FAA) in Italian patients. Am J Hum Genet 1997; 61: 1246–1253.
Levran O, Doggett NA, Auerbach AD . Identification of Alu-mediated deletions in the Fanconi anemia gene FAA. Hum Mutat 1998; 12: 145–152.
Grimwade D, Walker H, Oliver F, Wheatley K, Harrison C, Harrison G et al. The importance of diagnostic cytogenetics on outcome in AML: analysis of 1,612 patients entered into the MRC AML 10 trial. The Medical Research Council Adult and Children's Leukaemia Working Parties. Blood 1998; 92: 2322–2333.
Yau SC, Bobrow M, Mathew CG, Abbs SJ . Accurate diagnosis of carriers of deletions and duplications in Duchenne/Becker muscular dystrophy by fluorescent dosage analysis. J Med Genet 1996; 33: 550–558.
Clark SJ, Harrison J, Paul CL, Frommer M . High sensitivity mapping of methylated cytosines. Nucleic Acids Res 1994; 22: 2990–2997.
Grimwade D, Outram SV, Flora R, Ings SJ, Pizzey AR, Morilla R et al. The T-lineage-affiliated CD2 gene lies within an open chromatin environment in acute promyelocytic leukemia cells. Cancer Res 2002; 62: 4730–4735.
Gabert J, Beillard E, Van Der Velden VH, Bi W, Grimwade D, Pallisgaard N et al. Standardization and quality control studies of ‘real-time’ quantitative reverse transcriptase polymerase chain reaction of fusion gene transcripts for residual disease detection in leukemia – A Europe Against Cancer Program. Leukemia 2003; 17 (12): 2318–2357.
Baylin SB, Herman JG . DNA hypermethylation in tumorigenesis: epigenetics joins genetics. Trends Genet 2000; 16: 168–174.
Ianzano L, D'Apolito M, Centra M, Savino M, Levran O, Auerbach AD et al. The genomic organization of the Fanconi anemia group A (FAA) gene. Genomics 1997; 41: 309–314.
Butturini A, Gale RP, Verlander PC, Adler-Brecher B, Gillio AP, Auerbach AD . Hematologic abnormalities in Fanconi anemia: an International Fanconi Anemia Registry study. Blood 1994; 84: 1650–1655.
Pedersen-Bjergaard J, Rowley JD . The balanced and the unbalanced chromosome aberrations of acute myeloid leukemia may develop in different ways and may contribute differently to malignant transformation. Blood 1994; 83: 2780–2786.
van de Vrugt HJ, Cheng NC, de Vries Y, Rooimans MA, de Groot J, Scheper RJ et al. Cloning and characterization of murine fanconi anemia group A gene: Fanca protein is expressed in lymphoid tissues, testis, and ovary. Mamm Genome 2000; 11: 326–331.
Djuzenova CS, Rothfuss A, Oppitz U, Speit G, Schindler D, Hoehn H et al. Response to X-irradiation of Fanconi anemia homozygous and heterozygous cells assessed by the single-cell gel electrophoresis (comet) assay. Lab Invest 2001; 81: 185–192.
Pearson T, Jansen S, Havenga C, Stones DK, Joubert G . Fanconi anemia. A statistical evaluation of cytogenetic results obtained from South African families. Cancer Genet Cytogenet 2001; 126: 52–55.
Acknowledgements
We thank Professor David Linch for supplying samples from the MRC AML trials tissue bank at University College Hospital, London. These facilities have been supported by the Kay Kendall Leukemia Fund, the Medical Research Council and the Leukemia Research Fund of Great Britain. We thank Dr Cathryn Lewis for advice on statistical analysis and Grover C Bagby Jr who supplied probes for the RQ-PCR assay. MT was funded by Cancer Research UK. DG was supported by the Leukemia Research Fund of Great Britain, and equipment was provided by the Daniel Ayling Fanconi Anemia Trust.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Tischkowitz, M., Morgan, N., Grimwade, D. et al. Deletion and reduced expression of the Fanconi anemia FANCA gene in sporadic acute myeloid leukemia. Leukemia 18, 420–425 (2004). https://doi.org/10.1038/sj.leu.2403280
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.leu.2403280
Keywords
This article is cited by
-
Mutation spectrum, expression profiling, and prognosis evaluation of Fanconi anemia signaling pathway genes for 4259 patients with myelodysplastic syndromes or acute myeloid leukemia
BMC Medical Genomics (2023)
-
An effect of large-scale deletions and duplications on transcript expression
Functional & Integrative Genomics (2023)
-
Next-generation sequencing reveals novel variants and large deletion in FANCA gene in Polish family with Fanconi anemia
Orphanet Journal of Rare Diseases (2022)
-
Targeting PARP proteins in acute leukemia: DNA damage response inhibition and therapeutic strategies
Journal of Hematology & Oncology (2022)
-
Fanconi anemia pathway and its relationship with cancer
Genome Instability & Disease (2021)